TKG Advisors LLC Makes New Investment in Danaher Co. (NYSE:DHR)

TKG Advisors LLC bought a new position in Danaher Co. (NYSE:DHR) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 7,874 shares of the conglomerate’s stock, valued at approximately $2,189,000.

Several other institutional investors have also made changes to their positions in the company. nVerses Capital LLC acquired a new stake in Danaher during the 2nd quarter worth about $25,000. CarsonAllaria Wealth Management Ltd. purchased a new position in Danaher during the second quarter valued at approximately $25,000. MFA Wealth Advisors LLC acquired a new position in Danaher in the 2nd quarter valued at approximately $51,000. Financial Connections Group Inc. purchased a new stake in Danaher in the 2nd quarter worth approximately $51,000. Finally, Western Pacific Wealth Management LP acquired a new stake in shares of Danaher during the 1st quarter valued at $55,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Danaher

In related news, SVP Georgeann Couchara sold 952 shares of the company’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $268.37, for a total value of $255,488.24. Following the sale, the senior vice president now owns 4,212 shares of the company’s stock, valued at $1,130,374.44. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 11.10% of the stock is owned by insiders.

Analyst Ratings Changes

A number of research firms have recently weighed in on DHR. Royal Bank of Canada dropped their price target on shares of Danaher from $333.00 to $311.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 23rd. Wells Fargo & Company initiated coverage on Danaher in a research note on Tuesday, August 27th. They set an “equal weight” rating and a $280.00 price target for the company. Leerink Partners boosted their price target on Danaher from $275.00 to $280.00 and gave the company an “outperform” rating in a research note on Wednesday, July 24th. KeyCorp raised their price objective on shares of Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a research report on Wednesday, October 23rd. Finally, UBS Group decreased their target price on shares of Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a research report on Wednesday, October 23rd. Six equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. According to MarketBeat, Danaher has a consensus rating of “Moderate Buy” and a consensus price target of $287.16.

Danaher Stock Performance

DHR traded up $2.75 during midday trading on Monday, reaching $250.51. The company’s stock had a trading volume of 168,186 shares, compared to its average volume of 2,740,385. Danaher Co. has a twelve month low of $192.35 and a twelve month high of $281.70. The company has a fifty day simple moving average of $266.95 and a 200 day simple moving average of $260.66. The stock has a market cap of $180.94 billion, a P/E ratio of 47.28, a PEG ratio of 4.51 and a beta of 0.85. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.57 by $0.14. The firm had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The company’s quarterly revenue was up 3.1% compared to the same quarter last year. During the same period in the previous year, the company posted $2.02 earnings per share. Research analysts expect that Danaher Co. will post 7.51 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were paid a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.43%. The ex-dividend date was Friday, September 27th. Danaher’s dividend payout ratio is 20.61%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.